Evidence map›Paper›PMID 39200335›Full record

ReviewBiomedicines2024

The Role of Fecal Microbiota Transplantation (FMT) in the Management of Metabolic Diseases in Humans: A Narrative Review.

Eva Zikou, Chrysi Koliaki, Konstantinos Makrilakis

Abstract readReview
In one paragraph

Review in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Gut Microbiota and Metabolic Health: From Dysbiosis to Therapeutics.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eva ZikouFirst Department of Propaedeutic Internal Medicine and Diabetes Center, Medical Faculty, National and Kapodistrian University of Athens, "Laiko" General Hospital, 17 Agiou Thoma Street, 11527 Athens, Greece.ORCID 0009-0006-5554-5595
Chrysi KoliakiFirst Department of Propaedeutic Internal Medicine and Diabetes Center, Medical Faculty, National and Kapodistrian University of Athens, "Laiko" General Hospital, 17 Agiou Thoma Street, 11527 Athens, Greece.ORCID 0000-0003-3599-727X
Konstantinos MakrilakisFirst Department of Propaedeutic Internal Medicine and Diabetes Center, Medical Faculty, National and Kapodistrian University of Athens, "Laiko" General Hospital, 17 Agiou Thoma Street, 11527 Athens, Greece.ORCID 0000-0002-4160-0577

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota represents a complex ecosystem of trillions of microorganisms residing in the human gastrointestinal tract, which is known to interact with the host physiology and regulate multiple functions. Alterations in gut microbial composition, diversity, and function are referred to as dysbiosis. Dysbiosis has been associated with a variety of chronic diseases, including

Indexed as

fecal microbiota transplantationgut microbiotainsulin resistancemetabolic syndromeobesitytype 2 diabetes mellitus

Identifiers

PMID39200335
PMCPMC11352194

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.